Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ranibizumab is a monoclonal antibody fragment obtained from the same parental murine antibody as bevacizumab. It is an anti-angiogenic drug that has been approved for the treatment of AMD patients.
This report presents a comprehensive overview, market shares and growth opportunities of Ranibizumab market by product type, application, key companies and key regions. Biomedicine has achieved rapid growth in the global pharmaceutical market due to its high pharmacological activity, strong specificity, and good therapeutic effect. In the biopharmaceutical market, the monoclonal antibody is the most subdivided category. With the development of biotechnology, the research on monoclonal antibodies will be further deepened, and the patients' demand for monoclonal antibodies will also be further increased. Ranibizumab is mainly used for the treatment of age-related macular degeneration (AMD), a retinal disease that increases the incidence with age and causes a significant decrease in vision. Diabetic retinopathy and diabetic macular edema can also be treated with ranibizumab. Therefore, the deepening of global aging and the increasing incidence of chronic diseases such as diabetes will promote the expansion of demand for ranibizumab.
Indian pharmaceutical company Intas Pharmaceuticals has launched RAZUMAB™, a biosimilar of Lucentis® (Ranibizumab). The product is entirely manufactured in India, and the price of RAZUMAB™ is much cheaper than Lucentis®, which will allow the drug to be used in a wider patient population.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Ranibizumab market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Ranibizumab market. Detailed analysis of key players, along with key growth strategies adopted by Ranibizumab industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Genentech
Novartis
By Type:
Single-use prefilled syringe
Single-use glass vial
By End-User:
AMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Ranibizumab Market
-
1.3 Market Segment by Type
-
1.3.1 USA Ranibizumab Market Size and Growth Rate of Single-use prefilled syringe from 2016 to 2027
-
1.3.2 USA Ranibizumab Market Size and Growth Rate of Single-use glass vial from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Ranibizumab Market Size and Growth Rate of AMD from 2016 to 2027
-
1.4.2 USA Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR) from 2016 to 2027
-
1.4.3 USA Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME) from 2016 to 2027
-
1.4.4 USA Ranibizumab Market Size and Growth Rate of mCNV from 2016 to 2027
-
1.4.5 USA Ranibizumab Market Size and Growth Rate of RVO from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Ranibizumab Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Ranibizumab by Major Types
-
3.4.1 Market Size and Growth Rate of Single-use prefilled syringe
-
3.4.2 Market Size and Growth Rate of Single-use glass vial
4 Segmentation of Ranibizumab Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Ranibizumab by Major End-Users
-
4.4.1 Market Size and Growth Rate of Ranibizumab in AMD
-
4.4.2 Market Size and Growth Rate of Ranibizumab in Diabetic Retinopathy (DR)
-
4.4.3 Market Size and Growth Rate of Ranibizumab in Diabetic Macular Edema (DME)
-
4.4.4 Market Size and Growth Rate of Ranibizumab in mCNV
-
4.4.5 Market Size and Growth Rate of Ranibizumab in RVO
5 Market Analysis by Regions
-
5.1 USA Ranibizumab Production Analysis by Regions
-
5.2 USA Ranibizumab Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Ranibizumab Landscape Analysis
-
6.1 West USA Ranibizumab Landscape Analysis by Major Types
-
6.2 West USA Ranibizumab Landscape Analysis by Major End-Users
7 South USA Ranibizumab Landscape Analysis
-
7.1 South USA Ranibizumab Landscape Analysis by Major Types
-
7.2 South USA Ranibizumab Landscape Analysis by Major End-Users
8 Middle West USA Ranibizumab Landscape Analysis
-
8.1 Middle West USA Ranibizumab Landscape Analysis by Major Types
-
8.2 Middle West USA Ranibizumab Landscape Analysis by Major End-Users
9 Northeast USA Ranibizumab Landscape Analysis
-
9.1 Northeast USA Ranibizumab Landscape Analysis by Major Types
-
9.2 Northeast USA Ranibizumab Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Genentech
-
10.1.1 Genentech Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Novartis
-
10.2.1 Novartis Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Ranibizumab Market Size and Growth Rate of Single-use prefilled syringe from 2016 to 2027
-
Figure USA Ranibizumab Market Size and Growth Rate of Single-use glass vial from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Ranibizumab Market Size and Growth Rate of AMD from 2016 to 2027
-
Figure USA Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR) from 2016 to 2027
-
Figure USA Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME) from 2016 to 2027
-
Figure USA Ranibizumab Market Size and Growth Rate of mCNV from 2016 to 2027
-
Figure USA Ranibizumab Market Size and Growth Rate of RVO from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Ranibizumab Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Ranibizumab
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Ranibizumab by Different Types from 2016 to 2027
-
Table Consumption Share of Ranibizumab by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Single-use prefilled syringe
-
Figure Market Size and Growth Rate of Single-use glass vial
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Ranibizumab by Different End-Users from 2016 to 2027
-
Table Consumption Share of Ranibizumab by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of AMD
-
Figure Market Size and Growth Rate of Diabetic Retinopathy (DR)
-
Figure Market Size and Growth Rate of Diabetic Macular Edema (DME)
-
Figure Market Size and Growth Rate of mCNV
-
Figure Market Size and Growth Rate of RVO
-
Table USA Ranibizumab Production by Regions
-
Table USA Ranibizumab Production Share by Regions
-
Figure USA Ranibizumab Production Share by Regions in 2016
-
Figure USA Ranibizumab Production Share by Regions in 2021
-
Figure USA Ranibizumab Production Share by Regions in 2027
-
Table USA Ranibizumab Consumption by Regions
-
Table USA Ranibizumab Consumption Share by Regions
-
Figure USA Ranibizumab Consumption Share by Regions in 2016
-
Figure USA Ranibizumab Consumption Share by Regions in 2021
-
Figure USA Ranibizumab Consumption Share by Regions in 2027
-
Table West USA Ranibizumab Consumption by Types from 2016 to 2027
-
Table West USA Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure West USA Ranibizumab Consumption Share by Types in 2016
-
Figure West USA Ranibizumab Consumption Share by Types in 2021
-
Figure West USA Ranibizumab Consumption Share by Types in 2027
-
Table West USA Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table West USA Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Ranibizumab Consumption Share by End-Users in 2016
-
Figure West USA Ranibizumab Consumption Share by End-Users in 2021
-
Figure West USA Ranibizumab Consumption Share by End-Users in 2027
-
Table South USA Ranibizumab Consumption by Types from 2016 to 2027
-
Table South USA Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure South USA Ranibizumab Consumption Share by Types in 2016
-
Figure South USA Ranibizumab Consumption Share by Types in 2021
-
Figure South USA Ranibizumab Consumption Share by Types in 2027
-
Table South USA Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table South USA Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Ranibizumab Consumption Share by End-Users in 2016
-
Figure South USA Ranibizumab Consumption Share by End-Users in 2021
-
Figure South USA Ranibizumab Consumption Share by End-Users in 2027
-
Table Middle West USA Ranibizumab Consumption by Types from 2016 to 2027
-
Table Middle West USA Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Ranibizumab Consumption Share by Types in 2016
-
Figure Middle West USA Ranibizumab Consumption Share by Types in 2021
-
Figure Middle West USA Ranibizumab Consumption Share by Types in 2027
-
Table Middle West USA Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Ranibizumab Consumption Share by End-Users in 2016
-
Figure Middle West USA Ranibizumab Consumption Share by End-Users in 2021
-
Figure Middle West USA Ranibizumab Consumption Share by End-Users in 2027
-
Table Northeast USA Ranibizumab Consumption by Types from 2016 to 2027
-
Table Northeast USA Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Ranibizumab Consumption Share by Types in 2016
-
Figure Northeast USA Ranibizumab Consumption Share by Types in 2021
-
Figure Northeast USA Ranibizumab Consumption Share by Types in 2027
-
Table Northeast USA Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Ranibizumab Consumption Share by End-Users in 2016
-
Figure Northeast USA Ranibizumab Consumption Share by End-Users in 2021
-
Figure Northeast USA Ranibizumab Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
